|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.280 USD | -2.67% |
|
-0.27% | +267.68% |
| 04-09 | ImmunityBio, Inc. Reports Preliminary Revenue Results for the First Quarter Ended March 31, 2026 | CI |
| 04-09 | ImmunityBio Reports Preliminary Q1 Net Product Revenue | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 8.21 | 11.55 | 9.78 |
| Spread/Res. | -11.33% | -36.97% | -25.56% |
| Spread/Supp. | +9.31% | +29.08% | +62.14% |
| Support | 6.66 | 5.64 | 4.49 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- IBRX Stock
- Charts ImmunityBio, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition